Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - NeoPharm, Inc. (NasdaqNM:NEOL)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Recent Events
Aug  7Earnings Announcement
Location
150 Field Dirve, Suite 195
Lake Forest, IL 60045
Phone: (847) 295-8678
Fax: (847) 295-8854
Employees (last reported count): 35
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Related Links
 ·Search Yahoo! for related links...
Ownership
·Insider and 5%+ Owners: 36%
·Institutional: 56% (88% of float)
(88 institutions)
·Net Inst. Buying: 1.61M shares (+16.36%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
NeoPharm, Inc. is a biopharmaceutical company engaged in the research, development and commercialization of drugs for the treatment of various cancers. The Company has a portfolio of eight anti-cancer drugs, five of which are in clinical trials. The Company has built its drug portfolio based on its two novel proprietary technology platforms, an electrostatic liposome drug delivery platform and a tumor-targeting platform. The Company's NeoLipid Electrostatic Liposome Drug Delivery Platform uses charged lipids rather than neutral lipids. By encapsulating a drug within an oppositely charge liposome, the Company achieves an electrostatic attraction between these two agents, creating a stable drug formulation. The Company's tumor-targeting mechanism is a protein or monoclonal antibody that detects and binds to a specific marker on the surface of cancer cells.
More from Market Guide: Expanded Business Description

Financial Summary
NeoPharm, Inc., a biopharmaceutical company, is engaged in the research, development and commercialization of drugs for the diagnosis and treatment of various forms of cancer. For the six months ended 6/30/01, revenues totaled $0, down from $3 million. Net loss totaled $3.1 million vs. an income of $957 thousand. Revenues reflect the absence of a $3 million milestone payment from Pharmacia Corp. Net loss also reflects increased S/G/A expenses due to higher payroll expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

John Kapoor, Ph.D., 57
Chairman
--  
James Hussey, 41
Pres, CEO, Director
$688K
Lawrence Kenyon, 35
CFO, Sec.
--  
Jeffrey Sherman, M.D., 46
Exec. VP and CMO
--  
Lewis Strauss, M.D., 50
VP, Clinical Devel.
281K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:NEOLAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$14.563
Recent Price$17.94 
52-Week High
on 28-Sep-2000
$41.063
Beta1.83 
Daily Volume (3-month avg)69.0K
Daily Volume (10-day avg)25.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-35.1%
52-Week Change
relative to S&P500
-12.9%
Share-Related Items
Market Capitalization$263.0M
Shares Outstanding14.7M
Float9.40M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 16-Sep-1996
Per-Share Data
Book Value (mrq)$9.36 
Earnings (ttm)-$0.33 
Earnings (mrq)-$0.17 
SalesN/A 
Cash (mrq)$9.05 
Valuation Ratios
Price/Book (mrq)1.92 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
Sales (ttm)$0 
EBITDA (ttm)-$10.4M
Income available to common (ttm)-$4.57M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-4.01%
Return on Equity (ttm)-4.04%
Financial Strength
Current Ratio (mrq)146.21 
Debt/Equity (mrq)0 
Total Cash (mrq)$132.7M
Short Interest
As of 8-Aug-2001
Shares Short185.0K
Percent of Float2.0%
Shares Short
(Prior Month)
237.0K
Short Ratio2.85 
Daily Volume65.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.